Metagenomi Therapeutics (MGX) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Instil Bio (TIL) has outperformed Metagenomi Therapeutics (MGX) over the past year, losing 62.9% versus a loss of 66.6%. Instil Bio is the larger company by market cap ($44.5 million vs $37.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MGX | TIL |
|---|---|---|
| Share price | $0.9927 | $6.56 |
| Market cap | $37.50M | $44.49M |
| 1-day change | +0.81% | -4.23% |
| YTD return | -39.22% | -37.27% |
| 1-year return | -66.62% | -62.86% |
| 5-year return | — | -98.07% |
| EPS (TTM) | $-2.49 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.95 | $21.98 |
| 52-week low | $0.96 | $5.67 |
| Distance from 52-week high | -74.87% | -70.15% |
| Average volume | 155.71K | 11.93K |
| Shares outstanding | 37.78M | 6.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MGX vs TIL FAQ
Which is bigger, Metagenomi Therapeutics or Instil Bio?
Instil Bio (TIL) is larger, with a market capitalization of $44.49M compared with $37.50M for Metagenomi Therapeutics (MGX).
Which stock has performed better over the past year, MGX or TIL?
TIL returned -62.86% over the past 12 months, compared with -66.62% for MGX (price return, excluding dividends). Past performance does not predict future results.
Are Metagenomi Therapeutics and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.